Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 USD | +4.68% | +9.82% | +96.80% |
04-16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
04-16 | Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.80% | 30.28M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience : Closes $11 Million Public Offering